Stock ALB ALBEMARLE CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials Albemarle Corporation

Equities

ALB

US0126531013

Specialty Chemicals

Market Closed - Nyse
Other stock markets
 04:00:01 2024-04-26 pm EDT 		5-day change 1st Jan Change
116.9 USD +1.65% Intraday chart for Albemarle Corporation +4.22% -19.10%
Apr. 19 Albemarle, Cummins receive tax credits under Biden's clean energy drive RE
Apr. 15 Tesla supplier Piedmont Lithium gets key North Carolina mining permit RE

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 7,745 15,705 27,346 25,406 16,955 13,736 - -
Enterprise Value (EV) 1 10,182 18,530 29,301 27,124 20,232 17,685 17,356 18,528
P/E ratio 14.5 x 41.9 x 221 x 9.49 x 10.8 x 18.2 x 9.33 x 6.72 x
Yield 2.01% 1.04% 0.67% 0.73% - 1.41% 1.42% 1.47%
Capitalization / Revenue 2.16 x 5.02 x 8.22 x 3.47 x 1.76 x 2.28 x 1.86 x 1.57 x
EV / Revenue 2.84 x 5.92 x 8.8 x 3.71 x 2.1 x 2.93 x 2.35 x 2.12 x
EV / EBITDA 9.82 x 22.6 x 33.6 x 7.8 x 6 x 14.1 x 9.12 x 8.28 x
EV / FCF -76.9 x -359 x -48.1 x 42 x -24.6 x -44.8 x -142 x 55.8 x
FCF Yield -1.3% -0.28% -2.08% 2.38% -4.07% -2.23% -0.7% 1.79%
Price to Book 1.97 x 3.69 x 4.86 x 3.2 x 1.8 x 1.38 x 1.28 x 1.18 x
Nbr of stocks (in thousands) 106,033 106,457 116,976 117,153 117,353 117,525 - -
Reference price 2 73.04 147.5 233.8 216.9 144.5 116.9 116.9 116.9
Announcement Date 2/19/20 2/17/21 2/16/22 2/15/23 2/14/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 3,589 3,129 3,328 7,320 9,617 6,028 7,373 8,733
EBITDA 1 1,037 818.7 871 3,476 3,370 1,252 1,903 2,237
EBIT 1 823.3 586.8 617 3,175 2,940 610.4 1,259 1,608
Operating Margin 22.94% 18.75% 18.54% 43.37% 30.57% 10.13% 17.08% 18.41%
Earnings before Tax (EBT) 1 563 373.5 133.6 2,433 246.7 830.7 1,493 2,711
Net income 1 533.2 375.8 123.7 2,690 1,573 768.3 1,536 2,932
Net margin 14.86% 12.01% 3.72% 36.75% 16.36% 12.75% 20.84% 33.57%
EPS 2 5.020 3.520 1.060 22.84 13.36 6.408 12.53 17.40
Free Cash Flow 1 -132.4 -51.56 -609.4 646.2 -824 -395 -122.1 331.8
FCF margin -3.69% -1.65% -18.31% 8.83% -8.57% -6.55% -1.66% 3.8%
FCF Conversion (EBITDA) - - - 18.59% - - - 14.83%
FCF Conversion (Net income) - - - 24.02% - - - 11.32%
Dividend per Share 2 1.470 1.540 1.560 1.580 - 1.644 1.662 1.723
Announcement Date 2/19/20 2/17/21 2/16/22 2/15/23 2/14/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 830.6 894.2 1,128 1,480 2,092 2,621 2,580 2,370 2,311 2,356 1,363 1,399 1,588 1,830 1,487
EBITDA 1 217.6 228.7 431.9 610.2 1,190 1,244 1,596 1,032 453.3 289.1 187.8 249.9 344 429.7 414.4
EBIT 1 155.5 160.5 365.4 539.2 1,112 1,158 1,508 939.2 347.8 145 25.99 114.4 189.4 281.3 171
Operating Margin 18.72% 17.95% 32.4% 36.44% 53.17% 44.19% 58.46% 39.62% 15.05% 6.15% 1.91% 8.17% 11.93% 15.37% 11.5%
Earnings before Tax (EBT) 1 -516.8 -8.062 299.6 401.5 869.3 863.1 1,157 168.4 -158.2 -921 25 - - - -
Net income 1 -392.8 -3.824 253.4 406.8 897.2 1,132 1,239 650 302.5 -617.7 107.9 116.3 171.2 196.2 362
Net margin -47.29% -0.43% 22.47% 27.49% 42.89% 43.21% 48% 27.43% 13.09% -26.22% 7.91% 8.31% 10.78% 10.72% 24.35%
EPS 2 -3.360 -0.0300 2.150 3.460 7.610 9.600 10.51 5.520 2.570 -5.260 1.126 0.8800 1.310 1.763 3.080
Dividend per Share 2 0.3900 0.3900 0.3950 0.3950 0.3950 0.3950 0.4000 0.4000 0.4000 - 0.4120 0.4816 0.4850 0.4850 0.5942
Announcement Date 11/3/21 2/16/22 5/4/22 8/3/22 11/2/22 2/15/23 5/3/23 8/2/23 11/1/23 2/14/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 2,437 2,825 1,955 1,718 3,277 3,948 3,620 4,792
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 2.351 x 3.451 x 2.245 x 0.4943 x 0.9723 x 3.153 x 1.902 x 2.142 x
Free Cash Flow 1 -132 -51.6 -609 646 -824 -395 -122 332
ROE (net income / shareholders' equity) 17.1% 9.16% 8.31% 19% 30.1% 4.78% 12.6% 9.36%
ROA (Net income/ Total Assets) 7.37% 3.7% 4.39% 19.6% 15.5% 2.92% 6.8% 12.1%
Assets 1 7,237 10,156 2,817 13,745 10,128 26,334 22,610 24,178
Book Value Per Share 2 37.10 39.90 48.10 67.80 80.20 84.90 91.60 99.10
Cash Flow per Share 2 6.770 7.480 2.970 16.20 11.30 13.00 12.60 18.00
Capex 1 852 850 954 1,262 2,149 1,699 1,750 1,918
Capex / Sales 23.73% 27.18% 28.66% 17.24% 22.35% 28.18% 23.73% 21.96%
Announcement Date 2/19/20 2/17/21 2/16/22 2/15/23 2/14/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Albemarle Corporation

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
116.9 USD
Average target price
152.4 USD
Spread / Average Target
+30.39%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Specialty Chemicals

1st Jan change Capi.
ALBEMARLE CORPORATION Stock Albemarle Corporation
-19.10% 13.74B
ECOLAB INC. Stock Ecolab Inc.
+11.47% 63.22B
SIKA AG Stock Sika AG
-3.47% 46.34B
GIVAUDAN SA Stock Givaudan SA
+13.72% 39.97B
FUJIFILM HOLDINGS CORPORATION Stock Fujifilm Holdings Corporation
+17.83% 25.46B
EMS-CHEMIE HOLDING AG Stock EMS-CHEMIE HOLDING AG
+7.27% 18.68B
CELANESE CORPORATION Stock Celanese Corporation
-0.57% 17.24B
POSCO FUTURE M CO., LTD. Stock Posco Future M Co., Ltd.
-21.73% 15.81B
SYMRISE AG Stock Symrise AG
+0.22% 14.9B
NITTO DENKO CORPORATION Stock Nitto Denko Corporation
+35.12% 12.81B
Other Specialty Chemicals
  1. Stock Market
  2. Equities
  3. ALB Stock
  4. Financials Albemarle Corporation